A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients

NCT01836471 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

345

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: QAW039
DRUG: Placebo QAW039
DRUG: Fluticasone 250 mcg
DRUG: Fluticasone 100 mcg

Sponsor

Novartis Pharmaceuticals